Madely Health Headlines Commentary for December 14, 2009

Source:

Drug Combo boosts advanced breast cancer survival

Comment:

This approach to treatment applies only to HER-2 breast cancers that according to the article represents 1 in 4 breast cancers.

Related articles:

  1. More information needed about woman’s breast cancer before slamming Ontario Government for not covering breast-cancer drug
  2. Promising breast cancer treatment needs supporting studies
  3. Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
  4. Combination therapy for invasive non-metastatic HER-2 breast cancer shows promise
  5. Survival rates increase for Canadians with cancer: Statscan